Quick Dispatch:
Your clinical trials for retatrutide VisualAbstract: Retatrutide reduces body weight by 17.5% in patients with obesity orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your clinical trials for retatrutide VisualAbstract: Retatrutide reduces body weight by 17.5% in patients with obesity ships.
Need Help?
Questions about clinical trials for retatrutide VisualAbstract: Retatrutide reduces body weight by 17.5% in patients with obesity, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for clinical trials for retatrutide VisualAbstract: Retatrutide reduces body weight by 17.5% in patients with obesity in your area.
Eli Lilly infiltrates anti-obesity market as Phase III trial for retatrutide begins
26.24
Clinical trials of subcutaneous tirzepatide, retatrutide, and
20.44
Retatrutide—A Game Changer in Obesity Pharmacotherapy
23.99
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
29.52
Retatrutide: A Triple Agonist Shaping the Future of Metabolic Care
27.57
New Weight Loss Drug Retatrutide: My Patient's 85-Pound Journey (And What the Trials Don't Tell You)
26.26
Today we shared new results on retatrutide, an investigational, first-of-its-kind treatment we're studying in adults with obesity or overweight with at least one weight-related comorbidity. Read more about the Phase 3 findings:
26.59
